Cumberland Pharmaceuticals Inc CPIX

Morningstar Rating
$7.18 −0.36 (4.77%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CPIX is trading at a LOCK|Bnj@kP premium.
Price
$7.20
Fair Value
LOCK|@<MF$<p
Uncertainty
LOCK|TPD?&
1-Star Price
LOCK|.@MW>yp
5-Star Price
LOCK|WsC@tH$
Economic Moat
LOCK|sT
Capital Allocation
—

News

Trading Information

Previous Close Price
$7.54
Day Range
$7.00–7.58
52-Week Range
$1.88–9.28
Bid/Ask
$7.00 / $8.81
Shares Outstanding
14.98M
Market Cap
$107.58M
Volume/Avg
86,353 / 79,921

Key Statistics

Price/Earnings (Normalized)
55.33
Price/Sales
4.78
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
0.07%

Company Profile

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
93

Valuation

Metric
CPIX
Price/Earnings (Normalized)
55.33
Price/Book Value
6.16
Price/Sales
4.78
Price/Cash Flow
—
Price/Earnings
CPIX

Financial Strength

Metric
CPIX
Quick Ratio
0.49
Current Ratio
0.96
Interest Coverage
−42.20
Quick Ratio
CPIX

Profitability

Metric
CPIX
Return on Assets (Normalized)
−9.95%
Return on Equity (Normalized)
−29.02%
Return on Invested Capital (Normalized)
−21.49%
Return on Assets
CPIX

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|lfZ%prdLOCK|??x^R$70B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|&c><^H@LOCK|ZS$Z!$48B
Haleon PLC ADR
HLN
LOCK|^yYPq&MLOCK|@%$44B
Zoetis Inc Class A
ZTS
LOCK|mkL$qv>LOCK|sR$33B
Viatris Inc
VTRS
LOCK|Cg!Yz?LOCK|JBJ$21B
Elanco Animal Health Inc
ELAN
LOCK|JYQLOCK|$>$12B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|L<z?QW&LOCK|%V$11B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|<$M?@wLOCK|vH$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|r&%%JXzLOCK|hxqkY$2B
Perrigo Co PLC
PRGO
LOCK|S&fD$sRLOCK|d$$2B

Sponsor Center